Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis.

Kosuke EbinaM HiraoJ HashimotoH MatsuokaT IwahashiR ChijimatsuY EtaniG OkamuraA MiyamaH Yoshikawa

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2018)

Changes of systemic bone turnover induced by switching BPs to DMAb or TPTD may affect not only systemic bone mass, but also local joint destruction, and its clinical relevance should be considered comprehensively.

Keyphrases

bone mineral density
rheumatoid arthritis
postmenopausal women
body composition
disease activity
physical activity
interstitial lung disease
ankylosing spondylitis
soft tissue
systemic sclerosis
giant cell